Nicotinic–serotonergic interactions in brain and behaviour
- 30 April 2002
- journal article
- review article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 71 (4) , 795-805
- https://doi.org/10.1016/s0091-3057(01)00715-8
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric studyPublished by Elsevier ,2003
- Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetronLife Sciences, 1997
- Nicotinic Receptors in the Development and Modulation of CNS SynapsesPublished by Elsevier ,1996
- 5-Fluoronicotine, noranhydroecgonine, and pyridyl-methylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivoNeurochemical Research, 1995
- Effects of local and repeated systemic administration of (−)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortexNeurochemical Research, 1995
- Interaction between 5-HT1A and nicotinic cholinergic receptors in the regulation of water maze navigation behaviorBrain Research, 1994
- Effects of systemic nicotine on serotonin release in rat brainBrain Research, 1993
- In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotoninBrain Research, 1993
- The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmissionJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987